Fedratinib in Myelodysplastic /Myeloproliferative Neoplasms (MDS/MPNs) and Chronic Neutrophilic Leukemia (CNL)
Clinical trial NCT05177211 · COMPLETED
Trial details
- NCT number
- NCT05177211
- Sponsor
- H. Lee Moffitt Cancer Center and Research Institute
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-01
- Primary completion
- 2025-04-10
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.